These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. MicroRNA-598 acts as an inhibitor in retinoblastoma through targeting E2F1 and regulating AKT pathway. Liu F; Zhang Q; Liang Y J Cell Biochem; 2020 Mar; 121(3):2294-2302. PubMed ID: 31674056 [TBL] [Abstract][Full Text] [Related]
23. Single-cell characterization of malignant phenotypes and microenvironment alteration in retinoblastoma. Wu C; Yang J; Xiao W; Jiang Z; Chen S; Guo D; Zhang P; Liu C; Yang H; Xie Z Cell Death Dis; 2022 May; 13(5):438. PubMed ID: 35523772 [TBL] [Abstract][Full Text] [Related]
24. Weighted genes associated with the progression of retinoblastoma: Evidence from bioinformatic analysis. Zhou W; Guan W; Zhou Y; Rao Y; Ji X; Li J Exp Eye Res; 2021 Oct; 211():108730. PubMed ID: 34419445 [TBL] [Abstract][Full Text] [Related]
25. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression. Yang Y; Mei Q Mol Vis; 2015; 21():1307-17. PubMed ID: 26730174 [TBL] [Abstract][Full Text] [Related]
26. Focused cancer pathway analysis revealed unique therapeutic targets in retinoblastoma. Balaji S; Rao A; Saraswathi KK; Sethu Nagarajan R; Santhi R; Kim U; Muthukkaruppan V; Vanniarajan A Med Oncol; 2024 Jun; 41(7):168. PubMed ID: 38834895 [TBL] [Abstract][Full Text] [Related]
27. Retinoblastoma: expression of HLA-G. Adithi M; Kandalam M; Ramkumar HL; Subramanian A; Venkatesan N; Krishnakumar S Ocul Immunol Inflamm; 2006 Aug; 14(4):207-13. PubMed ID: 16911982 [TBL] [Abstract][Full Text] [Related]
28. LncRNA TMPO-AS1 up-regulates the expression of HIF-1α and promotes the malignant phenotypes of retinoblastoma cells via sponging miR-199a-5p. Peng X; Yan J; Cheng F Pathol Res Pract; 2020 Apr; 216(4):152853. PubMed ID: 32139259 [TBL] [Abstract][Full Text] [Related]
29. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism. Song WP; Zheng S; Yao HJ; Zhou XF; Li R; Zhang CY; Zhao JY; Wang LW; Shao RG; Li L BMC Ophthalmol; 2020 Mar; 20(1):92. PubMed ID: 32143590 [TBL] [Abstract][Full Text] [Related]
30. Circular RNA has_circ_0000034 accelerates retinoblastoma advancement through the miR-361-3p/ADAM19 axis. Jiang Y; Xiao F; Wang L; Wang T; Chen L Mol Cell Biochem; 2021 Jan; 476(1):69-80. PubMed ID: 32844346 [TBL] [Abstract][Full Text] [Related]
31. [The study on the correlation between telomerase and histopathologic features of retinoblastoma]. Ren RJ; Li B; Sun XL; Zheng BH; Li LQ; Chen CX Zhonghua Yan Ke Za Zhi; 2004 Apr; 40(4):234-8. PubMed ID: 15268829 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA‑448 inhibits the progression of retinoblastoma by directly targeting ROCK1 and regulating PI3K/AKT signalling pathway. Wu S; Ai N; Liu Q; Zhang J Oncol Rep; 2018 May; 39(5):2402-2412. PubMed ID: 29517104 [TBL] [Abstract][Full Text] [Related]
34. SP1-induced upregulation of lncRNA PANDAR predicts adverse phenotypes in retinoblastoma and regulates cell growth and apoptosis in vitro and in vivo. Sheng L; Wu J; Gong X; Dong D; Sun X Gene; 2018 Aug; 668():140-145. PubMed ID: 29778422 [TBL] [Abstract][Full Text] [Related]
35. microRNA -378a-3p Restrains the Proliferation of Retinoblastoma Cells but Promotes Apoptosis of Retinoblastoma Cells via Inhibition of FOXG1. Zhang C; Wu S Invest Ophthalmol Vis Sci; 2020 May; 61(5):31. PubMed ID: 32428232 [TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA MALAT1 aggravates human retinoblastoma by sponging miR-20b-5p to upregulate STAT3. Wang L; Zhang Y; Xin X Pathol Res Pract; 2020 Jun; 216(6):152977. PubMed ID: 32336590 [TBL] [Abstract][Full Text] [Related]
40. Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma. Salviat F; Gauthier-Villars M; Carton M; Cassoux N; Lumbroso-Le Rouic L; Dehainault C; Levy C; Golmard L; Aerts I; Doz F; Bonnet-Serrano F; Hayek S; Savignoni A; Stoppa-Lyonnet D; Houdayer C JAMA Ophthalmol; 2020 Aug; 138(8):843-850. PubMed ID: 32556071 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]